Efficacy of rituximab in patients with Graves’ orbitopathy: a retrospective multicenter nationwide study

被引：0
|
作者：
Jean-Baptiste Deltour
Marie d’Assigny Flamen
Miriam Ladsous
Lama Giovansili
Bertrand Cariou
Philippe Caron
Delphine Drui
Pierre Lebranchu
机构：
[1] CHU Nantes,Department of Ophthalmology, Hotel Dieu
[2] CHU Nantes,Department of Endocrinology Diabetes and Nutrition, L’institut du thorax
[3] Department of Endocrinology CHRU Lille,Department of Internal Medicine, Section of Endocrinology
[4] Fondation Ophtalmologique A de Rothschild,Department of Endocrinology, Metabolic Diseases and Nutrition, Pôle Cardio
[5] CHU Toulouse,Vasculaire et Métabolique
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2020年 / 258卷
关键词：
Rituximab; Anti-CD20 antibody; Graves’ orbitopathy; Basedow’s disease; Clinical activity score (CAS);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2013 / 2021
页数：8
相关论文
共 50 条
  • [41] Efficacy and safety of combined parenteral and oral steroid therapy in Graves’ orbitopathy
    Biljana Nedeljkovic Beleslin
    Jasmina Ciric
    Milos Zarkovic
    Mirjana Stojkovic
    Slavica Savic
    Miroslav Knezevic
    Branislav Stankovic
    Bozo Trbojevic
    Hormones, 2014, 13 : 222 - 228
  • [42] Efficacy and safety of combined parenteral and oral steroid therapy in Graves' orbitopathy
    Beleslin, Biljana Nedeljkovic
    Ciric, Jasmina
    Zarkovic, Milos
    Stojkovic, Mirjana
    Savic, Slavica
    Knezevic, Miroslav
    Stankovic, Branislav
    Trbojevic, Bozo
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2014, 13 (02): : 222 - 228
  • [43] Rituximab treatment for refractory nephrotic syndrome in adults: a multicenter retrospective study
    Ma, Xiaoyan
    Fang, Lu
    Sheng, Lili
    Zhou, Xun
    Bai, Shoujun
    Zang, Xiujuan
    Wang, Yakun
    Li, Mengke
    Lv, Zexin
    Zhong, Qin
    Yang, Xinyu
    Wang, Yishu
    Hu, Yan
    Yan, Danying
    Shi, Yingfeng
    Chen, Hui
    Li, Jinqing
    Tao, Min
    Zhuang, Shougang
    Wang, Yi
    Liu, Na
    RENAL FAILURE, 2023, 45 (01)
  • [44] Rituximab in refractory and non-refractory myasthenia: A retrospective multicenter study
    Collongues, Nicolas
    Casez, Olivier
    Lacour, Arnaud
    Tranchant, Christine
    Vermersch, Patrick
    de Seze, Jerome
    Lebrun, Christine
    MUSCLE & NERVE, 2012, 46 (05) : 687 - 691
  • [45] Efficacy and Side Effects of Lateral Orbital Wall Decompression Including the Orbital Rim in Patients with Graves' Orbitopathy
    Horn, Maren
    Schittkowski, Michael P.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2019, 236 (01) : 17 - 24
  • [46] Radioactive iodine (RAI) treatment of hyperthyroidism is safe in patients with Graves' orbitopathy - a prospective study
    Krol, Aleksandra
    Koehler, Aleksandra
    Nowak, Mariusz
    Paliczka-Cieslik, Ewa
    Krajewska, Jolanta
    Kalemba, Michal
    Jurecka-Lubieniecka, Beata
    Hasse-Lazar, Kornelia
    Michalik, Barbara
    Szpak-Ulczok, Sylwia
    Zarudzki, Lukasz
    Roskosz, Jozef
    Jarzab, Barbara
    ENDOKRYNOLOGIA POLSKA, 2014, 65 (01) : 40 - 45
  • [47] Efficacy and safety of rituximab in primary IgA nephropathy: a retrospective study
    Jingzhen Li
    Zhenyu Nie
    Guofu Li
    Beiyan Bao
    Clinical and Experimental Nephrology, 2025, 29 (5) : 616 - 623
  • [48] Comparative assessment of gut microbial composition and function in patients with Graves’ disease and Graves’ orbitopathy
    T.-T. Shi
    Z. Xin
    L. Hua
    H. Wang
    R.-X. Zhao
    Y.-L. Yang
    R.-R. Xie
    H.-Y. Liu
    J.-K. Yang
    Journal of Endocrinological Investigation, 2021, 44 : 297 - 310
  • [49] Efficacy and safety of rituximab in patients with chronic hypersensitivity pneumonitis (cHP): A retrospective, multicentric, observational study
    Ferreira, Marion
    Borie, Raphael
    Crestani, Bruno
    Rigaud, Pierre
    Wemeau, Lidwine
    Israel-Biet, Dominique
    Leroy, Sylvie
    Quetant, Sebastien
    Plantier, Laurent
    Dalphin, Jean-Charles
    Cottin, Vincent
    Marchand-Adam, Sylvain
    RESPIRATORY MEDICINE, 2020, 172
  • [50] A multicenter retrospective study on comparing the efficacy and safety of the therapy of intermittent cyclophosphamide and corticosteroids versus rituximab for primary membranous nephropathy
    Wang, Yi
    Ma, Xiaoyan
    Yang, Xinyu
    Bai, Shoujun
    Zang, Xiujuan
    Liao, Lin
    Wang, Yakun
    Lv, Zexin
    Zhang, Ting
    Zhuang, Shougang
    Liu, Na
    RENAL FAILURE, 2024, 46 (02)
12345